NPA7: A Dual Receptor Activating Peptide That Inhibits Cardiac Oxidative Stress

Overview

Journal Hypertension

Date 2025 Jan 8

PMID 39772591

Authors

Xiaoyu Ma

Joute Chawngvawr Malsawmzuali

J C Malsawmzuali

Dante G Moroni

Xiao Ma

Ye Zheng

Shuchong Pan

Ying Wang

S Jeson Sangaralingham

John C Burnett Jr

Affiliations

Soon will be listed here.

Abstract

Background: Cardiomyocyte oxidative stress significantly contributes to the progression of hypertension-induced heart failure, highlighting the need for targeted therapies. We developed a novel peptide, NPA7, that coactivates the GC-A (guanylyl cyclase A)/cGMP and MasR (Mas receptor)/cAMP pathway. This study aimed to test NPA7's ability to inhibit oxidative stress by modulating the p62 (Sequestosome 1)-KEAP1 (Kelch-like ECH-associated protein 1)-NRF2 (nuclear factor erythroid 2-related factor 2) pathway in human cardiomyocytes (HCMs) and a rat model of hypertension.

Methods: Oxidative stress was induced in HCMs using HO with phosphate-buffered saline or NPA7 treatment. Intracellular reactive oxygen species levels were assessed via dihydroethidium staining. Western blotting analysis measured p62, KEAP1, and NRF2 protein levels, while GSH/GSSG (glutathione/glutathione disulfide) ratios and antioxidant gene expression were analyzed. HCMs were transfected with small interfering RNA targeting GC-A, MasR, or p62 before NPA7 and HO treatment. In vivo, spontaneously hypertensive rats received saline or NPA7, with normotensive Wistar Kyoto rats as control and cardiac oxidative stress, KEAP1 protein levels, NOX2 (NADPH oxidase 2), and p67 (NADPH oxidase subunit p67-phox) mRNA levels were measured.

Results: NPA7 reduced HO-induced reactive oxygen species levels and increased GSH/GSSG ratio in HCMs. Silencing GC-A (guanylyl cyclase A receptor) and MasR (Mas receptor) reversed NPA7's effects. NPA7 activated the KEAP1-NRF2 pathway, enhancing NRF2's antioxidant target gene expression. In p62 knockdown HCMs, NPA7-induced KEAP1 degradation and NRF2 activation were diminished. Reactive oxygen species levels were elevated in spontaneously hypertensive rat versusWistar Kyoto rats' hearts, however, NPA7 treatment reduced myocardial reactive oxygen species, suppressed KEAP1 protein, and decreased NOX2 and p67 mRNA levels.

Conclusions: NPA7 exhibits antioxidant properties in HCMs and spontaneously hypertensive rat hearts by targeting GC-A and MasR through the p62-KEAP1-NRF2 pathway, supporting a novel therapeutic approach against cardiovascular disease-related oxidative stress.

References

Morimoto H, Mori J, Nakajima H, Kawabe Y, Tsuma Y, Fukuhara S . Angiotensin 1-7 stimulates brown adipose tissue and reduces diet-induced obesity. Am J Physiol Endocrinol Metab. 2017; 314(2):E131-E138. DOI: 10.1152/ajpendo.00192.2017. View

Rabelo L, Alenina N, Bader M . ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease. Hypertens Res. 2010; 34(2):154-60. DOI: 10.1038/hr.2010.235. View

Dodson M, Rojo de la Vega M, Cholanians A, Schmidlin C, Chapman E, Zhang D . Modulating NRF2 in Disease: Timing Is Everything. Annu Rev Pharmacol Toxicol. 2018; 59:555-575. PMC: 6538038. DOI: 10.1146/annurev-pharmtox-010818-021856. View

Touyz R, Rios F, Alves-Lopes R, Neves K, Camargo L, Montezano A . Oxidative Stress: A Unifying Paradigm in Hypertension. Can J Cardiol. 2020; 36(5):659-670. PMC: 7225748. DOI: 10.1016/j.cjca.2020.02.081. View

Patel V, Zhong J, Grant M, Oudit G . Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure. Circ Res. 2016; 118(8):1313-26. PMC: 4939482. DOI: 10.1161/CIRCRESAHA.116.307708. View

Kuhn M . Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A. Circ Res. 2003; 93(8):700-9. DOI: 10.1161/01.RES.0000094745.28948.4D. View

Packer M, McMurray J, Desai A, Gong J, Lefkowitz M, Rizkala A . Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure. Circulation. 2014; 131(1):54-61. DOI: 10.1161/CIRCULATIONAHA.114.013748. View

Preedy M, Baliga R, Hobbs A . Multiplicity of Nitric Oxide and Natriuretic Peptide Signaling in Heart Failure. J Cardiovasc Pharmacol. 2019; 75(5):370-384. DOI: 10.1097/FJC.0000000000000724. View

Chen Q, Maltagliati A . Nrf2 at the heart of oxidative stress and cardiac protection. Physiol Genomics. 2017; 50(2):77-97. PMC: 5867612. DOI: 10.1152/physiolgenomics.00041.2017. View

10.

Kansanen E, Kuosmanen S, Leinonen H, Levonen A . The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer. Redox Biol. 2013; 1:45-9. PMC: 3757665. DOI: 10.1016/j.redox.2012.10.001. View

11.

Mann G, Rowlands D, Li F, de Winter P, Siow R . Activation of endothelial nitric oxide synthase by dietary isoflavones: role of NO in Nrf2-mediated antioxidant gene expression. Cardiovasc Res. 2007; 75(2):261-74. DOI: 10.1016/j.cardiores.2007.04.004. View

12.

Pravenec M, Kurtz T . Recent advances in genetics of the spontaneously hypertensive rat. Curr Hypertens Rep. 2010; 12(1):5-9. PMC: 2821617. DOI: 10.1007/s11906-009-0083-9. View

13.

Volpe M, Gallo G, Rubattu S . Endocrine functions of the heart: from bench to bedside. Eur Heart J. 2022; 44(8):643-655. DOI: 10.1093/eurheartj/ehac759. View

14.

Ichimura Y, Waguri S, Sou Y, Kageyama S, Hasegawa J, Ishimura R . Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol Cell. 2013; 51(5):618-31. DOI: 10.1016/j.molcel.2013.08.003. View

15.

Wang C, Luo Z, Carter G, Wellstein A, Jose P, Tomlinson J . NRF2 prevents hypertension, increased ADMA, microvascular oxidative stress, and dysfunction in mice with two weeks of ANG II infusion. Am J Physiol Regul Integr Comp Physiol. 2017; 314(3):R399-R406. PMC: 5899246. DOI: 10.1152/ajpregu.00122.2017. View

16.

Cuadrado A, Rojo A, Wells G, Hayes J, Cousin S, Rumsey W . Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat Rev Drug Discov. 2019; 18(4):295-317. DOI: 10.1038/s41573-018-0008-x. View

17.

McKie P, Cataliotti A, Lahr B, Martin F, Redfield M, Bailey K . The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects. J Am Coll Cardiol. 2010; 55(19):2140-7. PMC: 3770189. DOI: 10.1016/j.jacc.2010.01.031. View

18.

Wang K, Basu R, Poglitsch M, Bakal J, Oudit G . Elevated Angiotensin 1-7/Angiotensin II Ratio Predicts Favorable Outcomes in Patients With Heart Failure. Circ Heart Fail. 2020; 13(7):e006939. DOI: 10.1161/CIRCHEARTFAILURE.120.006939. View

19.

Griendling K, Camargo L, Rios F, Alves-Lopes R, Montezano A, Touyz R . Oxidative Stress and Hypertension. Circ Res. 2021; 128(7):993-1020. PMC: 8293920. DOI: 10.1161/CIRCRESAHA.121.318063. View

20.

Bader M, Steckelings U, Alenina N, Santos R, Ferrario C . Alternative Renin-Angiotensin System. Hypertension. 2024; 81(5):964-976. PMC: 11023806. DOI: 10.1161/HYPERTENSIONAHA.123.21364. View